Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726–36.

Article  PubMed  CAS  Google Scholar 

Galderisi U, Peluso G, Di Bernardo G. Clinical trials based on mesenchymal stromal cells are exponentially increasing: Where are we in recent years? Stem Cell Rev Rep. 2022;18:23–36.

Article  PubMed  Google Scholar 

Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230–47.

Article  PubMed  CAS  Google Scholar 

Andrzejewska A, Lukomska B, Janowski M. Concise review: mesenchymal stem cells: from roots to boost. Stem Cells. 2019;37:855–64.

Article  PubMed  Google Scholar 

Bacakova L, Zarubova J, Travnickova M, Musilkova J, Pajorova J, Slepicka P, et al. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells—a review. Biotechnol Adv. 2018;36:1111–26.

Article  PubMed  Google Scholar 

Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, et al. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022;7:272.

Article  PubMed  PubMed Central  Google Scholar 

Zhou T, Yuan Z, Weng J, Pei D, Du X, He C, et al. Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol. 2021;14:24.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007;131:324–36.

Article  PubMed  CAS  Google Scholar 

Chan CKF, Gulati GS, Sinha R, Tompkins JV, Lopez M, Carter AC, et al. Identification of the human skeletal stem cell. Cell. 2018;175:43–56.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dennis JE, Caplan AI. Advances in mesenchymal stem cell biology. Curr Opin Orthop. 2004;15:341–6.

Article  Google Scholar 

Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12:383–96.

Article  PubMed  Google Scholar 

Kallmeyer K, Pepper MS. Homing properties of mesenchymal stromal cells. Expert Opin Biol Ther. 2015;15:477–9.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393:169–82.

Article  PubMed  Google Scholar 

Armstrong DK, Alvarez RD, Backes FJ, Bakkum-Gamez JN, Barroilhet L, Behbakht K, et al. NCCN Guidelines(R) insights: ovarian cancer, version 3.2022. J Natl Compr Canc Netw. 2022;20:972–80.

Article  PubMed  Google Scholar 

Makker V, MacKay H, Ray-Coquard I, Levine DA, Westin SN, Aoki D, et al. Endometrial cancer. Nat Rev Dis Primers. 2021;7:88.

Article  PubMed  PubMed Central  Google Scholar 

Dilruba S, Kalayda GV. Platinum-based drugs: past, present and future. Cancer Chemother Pharmacol. 2016;77:1103–24.

Article  PubMed  CAS  Google Scholar 

Wang X, Guo Z. Targeting and delivery of platinum-based anticancer drugs. Chem Soc Rev. 2013;42:202–24.

Article  PubMed  CAS  Google Scholar 

Lan T, Luo M, Wei X. Mesenchymal stem/stromal cells in cancer therapy. J Hematol Oncol. 2021;14:195.

Article  PubMed  PubMed Central  Google Scholar 

Zhang T, Lin R, Wu H, Jiang X, Gao J. Mesenchymal stem cells: a living carrier for active tumor-targeted delivery. Adv Drug Deliv Rev. 2022;185:114300.

Article  PubMed  CAS  Google Scholar 

Su L, Hao Y, Li R, Pan W, Ma X, Weng J, et al. Red blood cell-based vaccines for ameliorating cancer chemoimmunotherapy. Acta Biomater. 2022;154:401–11.

Article  PubMed  CAS  Google Scholar 

Fei Z, Fan Q, Dai H, Zhou X, Xu J, Ma Q, et al. Physiologically triggered injectable red blood cell-based gel for tumor photoablation and enhanced cancer immunotherapy. Biomaterials. 2021;271:120724.

Article  PubMed  CAS  Google Scholar 

Anderson NR, Minutolo NG, Gill S, Klichinsky M. Macrophage-based approaches for cancer immunotherapy. Cancer Res. 2021;81:1201–8.

Article  PubMed  CAS  Google Scholar 

Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21:799–820.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Met O, Jensen KM, Chamberlain CA, Donia M, Svane IM. Principles of adoptive T cell therapy in cancer. Semin Immunopathol. 2019;41:49–58.

Article  PubMed  Google Scholar 

Ribas A. T Cells as the future of cancer therapy. Cancer Discov. 2021;11:798–800.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wu HH, Zhou Y, Tabata Y, Gao JQ. Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic. J Control Release. 2019;294:102–13.

Article  PubMed  CAS  Google Scholar 

Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4:206–16.

Article  PubMed  CAS  Google Scholar 

Layek B, Sadhukha T, Prabha S. Glycoengineered mesenchymal stem cells as an enabling platform for two-step targeting of solid tumors. Biomaterials. 2016;88:97–109.

Article  PubMed  CAS  Google Scholar 

Xia C, Wang T, Cheng H, Dong Y, Weng Q, Sun G, et al. Mesenchymal stem cells suppress leukemia via macrophage-mediated functional restoration of bone marrow microenvironment. Leukemia. 2020;34:2375–83.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Niknejad H, Yazdanpanah G, Ahmadiani A. Induction of apoptosis, stimulation of cell-cycle arrest and inhibition of angiogenesis make human amnion-derived cells promising sources for cell therapy of cancer. Cell Tissue Res. 2016;363:599–608.

Article  PubMed  CAS  Google Scholar 

Liu QY, Ruan F, Li JY, Wei L, Hu P, Chen HW, et al. Human menstrual blood-derived stem cells inhibit the proliferation of HeLa cells via TGF-beta1-mediated JNK/P21 signaling pathways. Stem Cells Int. 2019;2019:9280298.

Article  PubMed  PubMed Central  Google Scholar 

Layek B, Sadhukha T, Panyam J, Prabha S. Nano-engineered mesenchymal stem cells increase therapeutic efficacy of anticancer drug through true active tumor targeting. Mol Cancer Ther. 2018;17:1196–206.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chastkofsky MI, Pituch KC, Katagi H, Zannikou M, Ilut L, Xiao T, et al. Mesenchymal stem cells successfully deliver oncolytic virotherapy to diffuse intrinsic pontine glioma. Clin Cancer Res. 2021;27:1766–77.

Article  PubMed  CAS  Google Scholar 

Han J, Hwang HS, Na K. TRAIL-secreting human mesenchymal stem cells engineered by a non-viral vector and photochemical internalization for pancreatic cancer gene therapy. Biomaterials. 2018;182:259–68.

Article  PubMed  CAS  Google Scholar 

Loebinger MR, Eddaoudi A, Davies D, Janes SM. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res. 2009;69:4134–42.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ridge SM, Sullivan FJ, Glynn SA. Mesenchymal stem cells: key players in cancer progression. Mol Cancer. 2017;16:31.

Article  PubMed  PubMed Central  Google Scholar 

Timaner M, Tsai KK, Shaked Y. The multifaceted role of mesenchymal stem cells in cancer. Semin Cancer Biol. 2020;60:225–37.

Article